Infliximab Weakens COVID Antibody Response for Patients With IBD ...Middle East

Although anti-tumor necrosis factor (anti-TNF) drugs are routinely used for patients with IBD, the impact of their immune-suppressing properties on protective immunity to COVID-19 is unknown. Medscape Medical News

Hence then, the article about infliximab weakens covid antibody response for patients with ibd was published today ( Thursday 25/03/2021 - 06:30 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Infliximab Weakens COVID Antibody Response for Patients With IBD )

Also on site :

• Iran’s new security boss Mohammad Zolghadr: Why his appointment matters
• Target’s Set of 2 Comfy Patio Chairs From a ‘Brady Bunch’ Star’s Brand Will Instantly Elevate Your Outdoor Space
• Miami lands 2027 commitment from ATH out of South Florida